Uptake of mIBG and catecholamines in noradrenaline- and organic cation transporter-expressing cells: potential use of corticosterone for a preferred uptake in neuroblastoma- and pheochromocytoma cells

Nuclear Medicine and Biology

Volumn 36, Issue 3, 2009, Pages 287-294

  Bayer, Melanie ^a   Kuçi, Zyrafete ^a   Schömig, Edgar ^c   Gründemann, Dirk ^c   Dittmann, Helmut ^b   Handgretinger, Rupert ^a   Bruchelt, Gernot ^a  

^a UNIVERSITY HOSPITAL TÜBINGEN   (Germany)

^b UNIVERSITY OF TÜBINGEN   (Germany)

^c UNIVERSITY OF COLOGNE   (Germany)

Author keywords

6 FDA; Catecholamine transporter; Corticosterone; mIBG; Neuroblastoma; Organic cation transporter

Indexed keywords

(3 IODOBENZYL)GUANIDINE I 123; 6 FLUORODOPA F 18; CATECHOLAMINE; CORTICOSTERONE; DOPAMINE; NORADRENALIN TRANSPORTER; ORGANIC CATION TRANSPORTER; ORGANIC CATION TRANSPORTER 1; ORGANIC CATION TRANSPORTER 2; ORGANIC CATION TRANSPORTER 3;

ARTICLE; COMPUTER ASSISTED EMISSION TOMOGRAPHY; CONTROLLED STUDY; GENETIC TRANSFECTION; HUMAN; HUMAN CELL; IRRADIATION; NEUROBLASTOMA CELL; PHEOCHROMOCYTOMA CELL; PROTEIN EXPRESSION;

3-IODOBENZYLGUANIDINE; ANIMALS; BIOLOGICAL TRANSPORT; CATECHOLAMINES; CELL LINE, TUMOR; CORTICOSTERONE; DESIPRAMINE; DOPAMINE; GENE EXPRESSION REGULATION, NEOPLASTIC; HUMANS; ION PUMPS; NEUROBLASTOMA; NOREPINEPHRINE PLASMA MEMBRANE TRANSPORT PROTEINS; ORGANIC CATION TRANSPORT PROTEINS; PHEOCHROMOCYTOMA;

EID: 62749184951     PISSN: 09698051     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.nucmedbio.2008.12.010     Document Type: Article

References (34)

1. Kadota T., Yamaai T., Saito Y., Akita Y., Kawashima S., Moroi K., et al. Expression of dopamine transporter at the tips of growing neurites of PC12 cells. J Histochem Cytochem 44 (1996) 989-996
2. Lode H.N., Bruchelt G., Seitz G., Gebhardt S., Gekeler V., Niethammer D., et al. Reverse transcriptase-polymerase chain reaction (RT-PCR) analysis of monoamine transporters in neuroblastoma cell lines: correlations to meta-iodobenzylguanidine (MIBG) uptake and tyrosine hydroxylase gene expression. Eur J Cancer 31A (1995) 586-590
3. Glowniak J.V., Kilty J.E., Amara S.G., Hoffman B.J., and Turner F.E. Evaluation of metaiodobenzylguanidine uptake by the norepinephrine, dopamine and serotonin transporters. J Nucl Med 34 (1993) 1140-1146
4. Ilias I., Yu J., Carrasquillo J.A., Chen C.C., Eisenhofer G., Whatley M., et al. Superiority of 6-[18F]-fluorodopamine positron emission tomography versus [131I]-metaiodobenzylguanidine scintigraphy in the localization of metastatic pheochromocytoma. J Clin Endocrinol Metab 88 (2003) 4083-4087
5. Mamede M., Carrasquillo J.A., Chen C.C., Del Corral P., Whatley M., Ilias I., et al. Discordant localization of 2-[18F]-fluoro-2-deoxy-d-glucose in 6-[18F]-fluorodopamine- and [(123)I]-metaiodobenzylguanidine-negative metastatic pheochromocytoma sites. Nucl Med Commun 27 (2006) 31-36
6. Pacak K., Eisenhofer G., Carrasquillo J.A., Chen C.C., Li S.T., and Goldstein D.S. 6-[18F]fluorodopamine positron emission tomographic (PET) scanning for diagnostic localization of pheochromocytoma. Hypertension 38 (2001) 6-8
7. Timmers H.J., Carrasquillo J.A., Whatley M., Eisenhofer G., Chen C.C., Ling A., et al. Usefulness of standardized uptake values for distinguishing adrenal glands with pheochromocytoma from normal adrenal glands by use of 6-18F-fluorodopamine PET. J Nucl Med 48 (2007) 1940-1944
8. Seitz G., Stegmann H.B., Jäger H.H., Schlude H.M., Wolburg H., Roginsky V.A., et al. Neuroblastoma cells expressing the noradrenaline transporter are destroyed more selectively by 6-fluorodopamine than by 6-hydroxydopamine. J Neurochem 75 (2000) 511-520
9. Schömig E., Lazar A., and Gründemann D. Extraneuronal monoamine transporter and organic cation transporters 1 and 2: a review of transport efficiency. Handb Exp Pharmacol (2006) 151-180
10. Gründemann D., Babin-Ebell J., Martel F., Ording N., Schmidt A., and Schömig E. Primary structure and functional expression of the apical organic cation transporter from kidney epithelial LLC-PK1 cells. J Biol Chem 272 (1997) 10408-10413
11. Gründemann D., Koster S., Kiefer N., Breidert T., Engelhardt M., Spitzenberger F., et al. Transport of monoamine transmitters by the organic cation transporter type 2, OCT2. J Biol Chem 273 (1998) 30915-30920
12. Gründemann D., Schechinger B., Rappold G.A., and Schömig E. Molecular identification of the corticosterone-sensitive extraneuronal catecholamine transporter. Nat Neurosci 1 (1998) 349-351
13. Hayer-Zillgen M., Bruss M., and Bonisch H. Expression and pharmacological profile of the human organic cation transporters hOCT1, hOCT2 and hOCT3. Br J Pharmacol 136 (2002) 829-836
14. Jonker J.W., and Schinkel A.H. Pharmacological and physiological functions of the polyspecific organic cation transporters: OCT1, 2, and 3 (SLC22A1-3). J Pharmacol Exp Ther 308 (2004) 2-9
15. Borowsky B., and Hoffman B.J. Neurotransmitter transporters: molecular biology, function, and regulation. Int Rev Neurobiol 38 (1995) 139-199
16. Breidert T., Spitzenberger F., Gründemann D., and Schömig E. Catecholamine transport by the organic cation transporter type 1 (OCT1). Br J Pharmacol 125 (1998) 218-224
17. Eisenhofer G. The role of neuronal and extraneuronal plasma membrane transporters in the inactivation of peripheral catecholamines. Pharmacol Ther 91 (2001) 35-62
18. Giros B., el Mestikawy S., Bertrand L., and Caron M.G. Cloning and functional characterization of a cocaine-sensitive dopamine transporter. FEBS Lett 295 (1991) 149-154
19. Goodman and Gilman`s. The pharmacological basis of therapeutics. eleventh ed (2006), McGraw-Hill, New York
20. Gründemann D., Gorboulev V., Gambaryan S., Veyhl M., and Koepsell H. Drug excretion mediated by a new prototype of polyspecific transporter. Nature 372 (1994) 549-552
21. Haag C., Berkels R., Gründemann D., Lazar A., Taubert D., and Schömig E. The localisation of the extraneuronal monoamine transporter (EMT) in rat brain. J Neurochem 88 (2004) 291-297
22. Ramamoorthy S., Prasad P.D., Kulanthaivel P., Leibach F.H., Blakely R.D., and Ganapathy V. Expression of a cocaine-sensitive norepinephrine transporter in the human placental syncytiotrophoblast. Biochemistry 32 (1993) 1346-1353
23. Bonnin F., Lumbroso J., Tenenbaum F., Hartmann O., and Parmentier C. Refining interpretation of MIBG scans in children. J Nucl Med 35 (1994) 803-810
24. Paltiel H.J., Gelfand M.J., Elgazzar A.H., Washburn L.C., Harris R.E., Masters P.R., et al. Neural crest tumors: I-123 MIBG imaging in children. Radiology 190 (1994) 117-121
25. Treuner J., Klingebiel T., Feine U., Buck J., Bruchelt G., Dopfer R., et al. Clinical experiences in the treatment of neuroblastoma with 131I-metaiodobenzylguanidine. Pediatr Hematol Oncol 3 (1986) 205-216
26. Gründemann D., Koschker A.C., Haag C., Honold C., Zimmermann T., and Schömig E. Activation of the extraneuronal monoamine transporter (EMT) from rat expressed in 293 cells. Br J Pharmacol 137 (2002) 910-918
27. Sisson J.C., Frager M.S., Valk T.W., Gross M.D., Swanson D.P., Wieland D.M., et al. Scintigraphic localization of pheochromocytoma. N Engl J Med 305 (1981) 12-17
28. Buck J., Bruchelt G., Girgert R., Treuner J., and Niethammer D. Specific uptake of m-[125I]iodobenzylguanidine in the human neuroblastoma cell line SK-N-SH. Cancer Res 45 (1985) 6366-6370
29. Pacholczyk T., Blakely R.D., and Amara S.G. Expression cloning of a cocaine- and antidepressant-sensitive human noradrenaline transporter. Nature 350 (1991) 350-354
30. Schömig E., Babin-Ebell J., Schonfeld C.L., Russ H., and Trendelenburg U. Human Caki-1 cells are the first model for extraneuronal transport of noradrenaline (uptake2) which is based on a clonal cell line. J Neural Transm Suppl 32 (1990) 437-440
31. Bruchelt G., Kuçi Z., Reischl G., Mueller I., Pirsig S., Handgretinger R., et al. [18F]6-FluoroDOPA and [18F]6-Fluorodopamine for PET in neuroblastoma: Comparative in vitro and first in vivo experiments using the small animal PET model. Advances in neuroblastoma research, abstract TR125 (2008) Chiba, Japan; May 21-24
32. Gründemann D., Liebich G., Kiefer N., Koster S., and Schömig E. Selective substrates for non-neuronal monoamine transporters. Mol Pharmacol 56 (1999) 1-10
33. Gorboulev V., Ulzheimer J.C., Akhoundova A., Ulzheimer-Teuber I., Karbach U., Quester S., et al. Cloning and characterization of two human polyspecific organic cation transporters. DNA Cell Biol 16 (1997) 871-881
34. Yonezawa A., Masuda S., Nishihara K., Yano I., Katsura T., and Inui K. Association between tubular toxicity of cisplatin and expression of organic cation transporter rOCT2 (Slc22a2) in the rat. Biochem Pharmacol 70 (2005) 1823-1831